miR—21—5p在肺动脉高压发病机制中的调控作用研究(4)
[14] Deng Z，Morse JH，Slager SL，et al. Familial primary pulmonary hypertension(gene PPH1)is caused by mutations in the bone morphogenetic protein receptor-II gene [J]. Am J Hum Genet，2000，67(3)：737-744.
[15] Soubrier F，Chung WK，Machado R，et al. Genetics and genomics of pulmonary arterial hypertension [J]. J Am Coll Cardiol，2013，62(25)：13-21.
[16] Wang J，Song Y，Zhang Y，et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice [J]. Cell Res，2012，22(3)：516-527.
[17] Yang J，Li X，AlLamki RS，et al. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo [J]. Circ Res，2010， 107(2)：252-262.
[18] Caruso P，Dempsie Y，Stevens HC，et al. A Role for miR-145 in Pulmonary Arterial Hypertension：Evidence From Mouse Models and Patient Samples[J]. Circ Res，2012，111(3)：290-300.
[19] Brock M，Samillan VJ，Trenkmann M，et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension [J]. European Heart Journal，2014，35(45)：3203-3211.
[20] Parikh VN，Jin RC，Rabello S，et al. MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension： Results of a Network Bioinformatics Approach [J]. Circulation，2012，125(12)：1520-1532.
(收稿日期：2016-07-13 本文编辑：程 铭), 百拇医药(张洪亮 董天崴 张磊艺)
[15] Soubrier F，Chung WK，Machado R，et al. Genetics and genomics of pulmonary arterial hypertension [J]. J Am Coll Cardiol，2013，62(25)：13-21.
[16] Wang J，Song Y，Zhang Y，et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice [J]. Cell Res，2012，22(3)：516-527.
[17] Yang J，Li X，AlLamki RS，et al. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo [J]. Circ Res，2010， 107(2)：252-262.
[18] Caruso P，Dempsie Y，Stevens HC，et al. A Role for miR-145 in Pulmonary Arterial Hypertension：Evidence From Mouse Models and Patient Samples[J]. Circ Res，2012，111(3)：290-300.
[19] Brock M，Samillan VJ，Trenkmann M，et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension [J]. European Heart Journal，2014，35(45)：3203-3211.
[20] Parikh VN，Jin RC，Rabello S，et al. MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension： Results of a Network Bioinformatics Approach [J]. Circulation，2012，125(12)：1520-1532.
(收稿日期：2016-07-13 本文编辑：程 铭), 百拇医药(张洪亮 董天崴 张磊艺)